Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Works by Matoba, Kenta
Results: 5
1
2
Hypertriglyceridemia and younger age are associated with effectiveness of growth hormone therapy on hepatic steatosis.
- Published in:
- Endocrine Journal, 2025, v. 72, n. 4, p. 355, doi. 10.1507/endocrj.EJ24-0481
- By:
- Publication type:
- Article
3
Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging.
- Published in:
- Endocrine Journal, 2024, v. 71, n. 8, p. 767, doi. 10.1507/endocrj.EJ24-0005
- By:
- Publication type:
- Article
4
Clinical feasibility of remote intermittently scanned continuous glucose monitoring in coronavirus disease 2019 patients with and without diabetes during dexamethasone therapy.
- Published in:
- Endocrine Journal, 2022, v. 69, n. 5, p. 597, doi. 10.1507/endocrj.ej21-0540
- By:
- Publication type:
- Article
5
Evaluation of the relationship between hemodialysis-related glycemic variability and hormonal profiles in patients with type 2 diabetes on hemodialysis: a pilot study.
- Published in:
- Renal Replacement Therapy, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s41100-022-00429-0
- By:
- Publication type:
- Article